Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2020.12.17

Sai Life Sciences announces plans to recruit 500+ scientists in 2021

Recruiting Scientific Positions

• Immediately initiates first phase of recruitment for 100 scientists in API process development and scale-up
• To initiate recruitment for 400 positions across Discovery Chemistry, Biology & DMPK in a phased manner over the year

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced its plans to recruit over 500 scientists during the year 2021. As the first phase of this drive, the company has initiated recruitment for scientific talent in API process and analytical research & development, particle science and engineering , niche platform technologies as well as life cycle management.

Making the announcement, Krishna Kanumuri, CEO & Managing Director, Sai Life Sciences said, “Over the past 18-24 months we have been significantly augmenting our R&D facilities and rapidly growing our customer outreach. We expect these efforts to bear fruit in the coming months and are therefore looking to expand our team. This addition to our high-quality talent pool will help us better serve our customers by accelerating their projects involving complex chemistry and next generation technologies.”

As part of the current recruitment drive, the company is looking to on-board top-notch global scientific talent with M.Sc./ Ph.D / Post Doctorates in synthetic organic / analytical chemistry from reputed academic institutions, and experience in global pharma R&D of up to 20 years, across various levels. The company also has positions open for Technology Transfer focused Process Engineers and Program Managers. The full list of open positions can be viewed here.

Marking the completion of 20 years since its inception in 2019, the company announced Sai Nxt, an organisation-wide initiative aimed at transforming itself into a new generation CRO/CDMO. Guided by the insights and feedback from its customers, it committed to investing over US$150M between 2019 and 2023 to significantly expand and upgrade its R&D and manufacturing facilities, deepen scientific & technological capabilities, strengthen automation and data systems, and above all raise the bar for safety, quality and customer focus.

As part of Sai Nxt, the company has added 172 KL API & Intermediate manufacturing capacity, opened a discovery biology Lab in Cambridge, Massachusetts, USA, a centre of excellence in process R&D in Manchester, UK and an 83,000 sq. ft. integrated research & technology facility in Hyderabad with technology platforms including flow chemistry, biocatalysis and crystallization. It became the first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI). The company is now in the process of adding high potent capability in R&D and manufacturing, a new clean room block and 200KL additional manufacturing capacity.

Share article

News

2021.07.26

Sai Life Sciences Wins Golden Peacock National Training Award 2021

Sai Life Sciences Wins Golden Peacock National Training Award 2021

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced that it has been honoured with the Golden Peacock National Training Award 2021 in the pharmaceutical category. This is the second consecutive Golden Peacock Award for the company following the Golden Peacock National Quality Award it received in […]
Read more

2021.06.30

Sai Life Sciences partners with Roshini Trust for an initiative in support of Mental Health.

Sai Life Sciences partners with Roshini Trust for an initiative in support of Mental Health.

For an ailment in the body, we seek medical attention. What about the mind? Conditions such as stress, anxiety, mood swings and depression caused by loss of a loved one, trauma, lifestyle change or biological changes can impact your mental state. At Sai Life Sciences, we empathize with such situations and believe that it is […]
Read more

2021.04.01

Sustainable transformation stemming from the shop floor

Sustainable transformation
stemming from the shop floor

“You’ll never change your life unless you change something you do daily.” This well-known quote by John Maxwell rings true in the context of our shop floor management. We began with a small pilot of an interactive and inclusive program we call Shop Floor Transformation Initiative (SFTI) in one of our production blocks in December […]
Read more

2021.03.26

CII-SR EHS Excellence Awards

Sai Life Sciences manufacturing facility achieves 5-star rating at CII-SR EHS Excellence Awards

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO/ CDMO), today announced that its flagship manufacturing facility in Bidar, Karnataka received a 5-star rating for excellence in EHS practices at the 13th edition of the Confederation of Indian Industry’s (CII-SR) EHS Excellence Awards. This is the second consecutive year […]
Read more

2021.03.24

Clean room block

Sai Life Sciences opens new clean room block at its manufacturing campus

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the opening of a new Clean Room block at its cGMP API & Intermediate Manufacturing campus in Bidar, India. Making the announcement, Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences said, “Over the last two years […]
Read more